DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
Teradata Corp
TDC
Hutchmed (China)
HCM
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 233.89%798K | 1,057.63%683K | 1.16M | 470K | 391K | 239K | 59K | 0 | 0 | 0 |
Operating revenue | 233.89%798K | 1,057.63%683K | --1.16M | --470K | --391K | --239K | --59K | --0 | --0 | --0 |
Cost of revenue | 335.65%1.88M | 235.31%1.02M | 344.32%2.47M | 219.16%983K | 1,000.00%748K | 141.34%432K | 303K | 555K | 308K | 68K |
Gross profit | -461.66%-1.08M | -36.07%-332K | -135.50%-1.31M | -66.56%-513K | -423.53%-356K | -7.82%-193K | -244K | -555K | -308K | -68K |
Operating expense | -32.25%11.75M | -15.25%13.25M | 19.80%61.7M | -11.40%12.12M | 19.12%16.61M | 39.37%17.34M | 36.63%15.63M | 70.49%51.5M | 37.76%13.68M | 86.23%13.94M |
Selling and administrative expenses | -29.85%7.16M | -33.81%7.24M | 7.62%37.34M | -32.75%6.42M | 9.25%9.77M | 27.80%10.21M | 33.14%10.94M | 88.47%34.69M | 53.54%9.55M | 80.88%8.94M |
-General and administrative expense | -29.85%7.16M | -33.81%7.24M | 7.62%37.34M | -32.75%6.42M | 9.25%9.77M | 27.80%10.21M | 33.14%10.94M | 88.47%34.69M | 53.54%9.55M | 80.88%8.94M |
Research and development costs | -35.69%4.59M | 27.99%6.01M | 44.93%24.36M | 37.96%5.7M | 36.76%6.84M | 60.15%7.13M | 45.54%4.7M | 42.43%16.81M | 11.32%4.13M | 96.62%5M |
Operating profit | 26.82%-12.83M | 14.46%-13.58M | -21.03%-63.01M | 9.69%-12.63M | -21.08%-16.96M | -38.93%-17.53M | -38.77%-15.88M | -72.32%-52.06M | -40.86%-13.99M | -87.14%-14.01M |
Net non-operating interest income expense | -1.42%-927K | -510.13%-964K | -9,606.67%-2.91M | -922.32%-921K | -1,897.83%-919K | -1,804.17%-914K | -229.17%-158K | 96.13%-30K | 128.14%112K | 19.30%-46K |
Non-operating interest expense | 1.42%927K | 510.13%964K | 9,606.67%2.91M | 922.32%921K | 1,897.83%919K | 1,804.17%914K | 229.17%158K | -96.13%30K | -128.14%-112K | -19.30%46K |
Other net income (expense) | -126.39%-270K | 52.35%1.49M | 122.22%1.63M | 86.26%-999K | 142.80%624K | 893.02%1.02M | 685.63%978K | 44.08%-7.31M | 29.63%-7.27M | 161.19%257K |
Gain on sale of security | -66.55%476K | 19.07%1.49M | 334.12%2.39M | -425.83%-883K | 7.72%600K | 755.76%1.42M | 841.42%1.25M | 493.57%551K | 290.85%271K | 7,062.50%557K |
Special income (charges) | ---795K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Less:Other special charges | --624K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | ---171K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 112.25%49K | 99.27%-2K | 90.25%-767K | 98.46%-116K | 108.00%24K | -554.55%-400K | -13,850.00%-275K | -222.92%-7.86M | -2,557.33%-7.54M | 27.18%-300K |
Income before tax | 19.49%-14.03M | 13.28%-13.06M | -8.24%-64.3M | 31.18%-14.56M | -25.08%-17.26M | -36.17%-17.43M | -29.18%-15.06M | -34.82%-59.4M | -2.36%-21.15M | -73.30%-13.8M |
Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income | 19.49%-14.03M | 13.28%-13.06M | -8.24%-64.3M | 31.18%-14.56M | -25.08%-17.26M | -36.17%-17.43M | -29.18%-15.06M | -34.82%-59.4M | -2.36%-21.15M | -73.30%-13.8M |
Net income continuous Operations | 19.49%-14.03M | 13.28%-13.06M | -8.24%-64.3M | 31.18%-14.56M | -25.08%-17.26M | -36.17%-17.43M | -29.18%-15.06M | -34.82%-59.4M | -2.36%-21.15M | -73.30%-13.8M |
Minority interest income | 44.32%-671K | 11.04%-854K | -13.05%-4.05M | 13.72%-849K | 1.24%-1.04M | -45.18%-1.21M | -33.33%-960K | -306.46%-3.59M | -49.32%-984K | -371.30%-1.05M |
Net income attributable to the parent company | 17.64%-13.36M | 13.44%-12.2M | -7.93%-60.24M | 32.03%-13.71M | -27.25%-16.22M | -35.53%-16.22M | -28.91%-14.1M | -29.27%-55.82M | -0.82%-20.17M | -64.71%-12.75M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 17.64%-13.36M | 13.44%-12.2M | -7.93%-60.24M | 32.03%-13.71M | -27.25%-16.22M | -35.53%-16.22M | -28.91%-14.1M | -29.27%-55.82M | -0.82%-20.17M | -64.71%-12.75M |
Basic earnings per share | 45.10%-0.28 | 40.00%-0.27 | 2.15%-1.82 | 46.27%-0.36 | -16.28%-0.5 | -27.50%-0.51 | -21.62%-0.45 | -10.71%-1.86 | 8.22%-0.67 | -48.28%-0.43 |
Diluted earnings per share | 45.10%-0.28 | 40.00%-0.27 | 2.15%-1.82 | 46.27%-0.36 | -16.28%-0.5 | -27.50%-0.51 | -21.62%-0.45 | -10.71%-1.86 | 8.22%-0.67 | -48.28%-0.43 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |